Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,098.19
+21.561.04%
Number of Gainers:5
Number of Losers:5
Number of Flat:1
PE:- -
High:2,099.36
Open:2,080.12
Low:2,074.95
Close:2,076.62
Volume:2.85M
Turnover:155.92M
Market Cap:231.30B
Float Cap:230.59B

Loading ...

GeoVax Appeals NASDAQ Delisting Notice Tied to Minimum Bid Price Rule

Reuters
·
Sep 11

Apple Health app users can order labs from Quest Diagnostics

TIPRANKS
·
Sep 10

Quest Diagnostics Lab Testing to be Available for Purchase in Apple Health App Later This Year

Reuters
·
Sep 10

Viatris Price Target Announced at $20.00/Share by Leerink Partners

Dow Jones
·
Sep 09

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Sep 09

Leerink Starts Viatris at 'outperform' on Improving Growth

Reuters
·
Sep 09

Emergent Biosolutions Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 09

Viatris Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Price Target $20

THOMSON REUTERS
·
Sep 09

Viatris initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Sep 09

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

TradingKey
·
Sep 09

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS
·
Sep 09

Quest Diagnostics Inc : UBS Raises Target Price to $245 from $232

THOMSON REUTERS
·
Sep 08

Viatris Price Target Raised to $20.00/Share from $15.00 by Argus Research

Dow Jones
·
Sep 08

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

Reuters
·
Sep 08

Argus Adjusts Price Target on Viatris to $20 From $18, Keeps Buy Rating

MT Newswires Live
·
Sep 08